175 related articles for article (PubMed ID: 38255924)
21. Combining Ramachandran plot and molecular dynamics simulation for structural-based variant classification: Using
Tam B; Sinha S; Wang SM
Comput Struct Biotechnol J; 2020; 18():4033-4039. PubMed ID: 33363700
[TBL] [Abstract][Full Text] [Related]
22. A functional assay-based procedure to classify mismatch repair gene variants in Lynch syndrome.
Drost M; Tiersma Y; Thompson BA; Frederiksen JH; Keijzers G; Glubb D; Kathe S; Osinga J; Westers H; Pappas L; Boucher KM; Molenkamp S; Zonneveld JB; van Asperen CJ; Goldgar DE; Wallace SS; Sijmons RH; Spurdle AB; Rasmussen LJ; Greenblatt MS; de Wind N; Tavtigian SV
Genet Med; 2019 Jul; 21(7):1486-1496. PubMed ID: 30504929
[TBL] [Abstract][Full Text] [Related]
23. Expression defect size among unclassified MLH1 variants determines pathogenicity in Lynch syndrome diagnosis.
Hinrichsen I; Brieger A; Trojan J; Zeuzem S; Nilbert M; Plotz G
Clin Cancer Res; 2013 May; 19(9):2432-41. PubMed ID: 23403630
[TBL] [Abstract][Full Text] [Related]
24. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
[TBL] [Abstract][Full Text] [Related]
25. Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.
Ellison AR; Lofing J; Bitter GA
Nucleic Acids Res; 2004; 32(18):5321-38. PubMed ID: 15475387
[TBL] [Abstract][Full Text] [Related]
26. Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity.
Farrell MP; Hughes DJ; Drost M; Wallace AJ; Cummins RJ; Fletcher TA; Meany MA; Kay EW; de Wind N; Power DG; Andrews EJ; Green AJ; Gallagher DJ
Fam Cancer; 2013 Dec; 12(4):741-7. PubMed ID: 23712482
[TBL] [Abstract][Full Text] [Related]
27. Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.
Houlleberghs H; Dekker M; Lantermans H; Kleinendorst R; Dubbink HJ; Hofstra RM; Verhoef S; Te Riele H
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4128-33. PubMed ID: 26951660
[TBL] [Abstract][Full Text] [Related]
28. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing].
Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589
[No Abstract] [Full Text] [Related]
29. Identification of deleterious variants of uncertain significance in BRCA2 BRC4 repeat through molecular dynamics simulations.
Sinha S; Qin Z; Tam B; Wang SM
Brief Funct Genomics; 2022 May; 21(3):202-215. PubMed ID: 35325018
[TBL] [Abstract][Full Text] [Related]
30. A Novel Germline
Klančar G; Blatnik A; Šetrajčič Dragoš V; Vogrič V; Stegel V; Blatnik O; Drev P; Gazič B; Krajc M; Novaković S
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32197529
[TBL] [Abstract][Full Text] [Related]
31. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
[TBL] [Abstract][Full Text] [Related]
32. Identification of Lynch Syndrome.
Maratt JK; Stoffel E
Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):45-58. PubMed ID: 34798986
[TBL] [Abstract][Full Text] [Related]
33. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.
Rosty C; Clendenning M; Walsh MD; Eriksen SV; Southey MC; Winship IM; Macrae FA; Boussioutas A; Poplawski NK; Parry S; Arnold J; Young JP; Casey G; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Potter JD; DeRycke M; Lindor NM; Thibodeau SN; Baron JA; Win AK; Hopper JL; Jenkins MA; Buchanan DD;
BMJ Open; 2016 Feb; 6(2):e010293. PubMed ID: 26895986
[TBL] [Abstract][Full Text] [Related]
34. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
35. Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies.
Hardt K; Heick SB; Betz B; Goecke T; Yazdanparast H; Küppers R; Servan K; Steinke V; Rahner N; Morak M; Holinski-Feder E; Engel C; Möslein G; Schackert HK; von Knebel Doeberitz M; Pox C; ; ; Hegemann JH; Royer-Pokora B
Fam Cancer; 2011 Jun; 10(2):273-84. PubMed ID: 21404117
[TBL] [Abstract][Full Text] [Related]
36. A novel germline frameshift mutation in the MLH1 gene in a patient with Lynch syndrome.
Xu J; Song J; Zhu W; Zuo L; Wu J; Zhang L; Wang T; Guo J
Cancer Genet; 2023 Jun; 274-275():54-58. PubMed ID: 37001204
[TBL] [Abstract][Full Text] [Related]
37. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
[TBL] [Abstract][Full Text] [Related]
38. Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cells.
Rath A; Mishra A; Ferreira VD; Hu C; Omerza G; Kelly K; Hesse A; Reddi HV; Grady JP; Heinen CD
Hum Mutat; 2019 Nov; 40(11):2044-2056. PubMed ID: 31237724
[TBL] [Abstract][Full Text] [Related]
39. Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals.
Valentin MD; da Silva FC; dos Santos EM; Lisboa BG; de Oliveira LP; Ferreira Fde O; Gomy I; Nakagawa WT; Aguiar Junior S; Redal M; Vaccaro C; Valle AD; Sarroca C; Carraro DM; Rossi BM
Fam Cancer; 2011 Dec; 10(4):641-7. PubMed ID: 21681552
[TBL] [Abstract][Full Text] [Related]
40. MLH1 Exon 12 Gene Deletion Leading to Lynch Syndrome: A Case Report.
Cui S; Zhang X; Zou R; Ye F; Wang Y; Sun J
Oncol Res Treat; 2021; 44(7-8):414-421. PubMed ID: 34091457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
